Browse by category

Costs of obesity management medications exceeds BMS in less than a year

The cost of taking weekly injections of popular obesity management medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that...

Bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection

For patients with type 2 diabetes, obesity and chronic kidney disease, bariatric surgery was associated with a significant decrease in...

Amycretin achieves 13% weight loss within three months with once-a-day tablet

Individuals who received a once-a-day oral weight loss drug, Amycretin developed by Novo Nordisk, lost up to 13% of their body weight...

Strong relationship between the increase in metabolic activity caused by once-daily GLP-1 and the amount of weight lost

A study carried out in St Vincent's University Hospital (SVUH) Dublin, Ireland, challenges the belief that weight-loss medications such...

GLP-1 RAs alone are not enough for individuals to achieve health goals

A group of obesity management professionals led by University College London have acknowledged the promise of the new generation of...

Popularity of GLP-1s among privately insured patients may worsen disparities

Publicly insured US individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than...

Surging US medical costs have employers taking a hard look at the return on investment

Only about half of US employers (52%) say they effectively manage healthcare costs, according to Gallagher's 2024 US Physical & Emotional...

Roche’s oral GLP-1 receptor agonist CT-996 has weight loss of -6.1% within four weeks

Roche has reported positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational,...

AI analysis finds huge public interest in GLP-1 drugs for weight loss and mental health benefits

Using a large language models (LLMs) to analyse over 391,000 unique discussions related to glucagon-like peptide-1 (GLP-1) receptor...

Harnessing network of CNS proteins could increase effectiveness of GLP-1s

A network of proteins found in the central nervous system could be harnessed to increase the effectiveness and reduce the side effects of...

Ratioing the resected gastric volume to the number of fired staplers predicts weight loss

Dec 30, 2024

Arrowhead initiates phase 1/2a study of ARO-INHBE for obesity

Dec 29, 2024

Survey finds 93.4% of bariatric patients vs 51.4% of GLP-1 patients have the same treatment again

Dec 26, 2024

Weekly Digest